JP2024520202A5 - - Google Patents
Info
- Publication number
- JP2024520202A5 JP2024520202A5 JP2023571449A JP2023571449A JP2024520202A5 JP 2024520202 A5 JP2024520202 A5 JP 2024520202A5 JP 2023571449 A JP2023571449 A JP 2023571449A JP 2023571449 A JP2023571449 A JP 2023571449A JP 2024520202 A5 JP2024520202 A5 JP 2024520202A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- amino acid
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163191076P | 2021-05-20 | 2021-05-20 | |
| US63/191,076 | 2021-05-20 | ||
| PCT/IB2022/054701 WO2022243937A1 (en) | 2021-05-20 | 2022-05-19 | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520202A JP2024520202A (ja) | 2024-05-22 |
| JP2024520202A5 true JP2024520202A5 (enExample) | 2025-05-28 |
Family
ID=81927398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571449A Pending JP2024520202A (ja) | 2021-05-20 | 2022-05-19 | Ｉｌ－２３に対する抗体及びｔｎｆアルファに対する抗体の組み合わせ療法を用いた炎症性腸疾患を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220372129A1 (enExample) |
| EP (1) | EP4340875A1 (enExample) |
| JP (1) | JP2024520202A (enExample) |
| KR (1) | KR20240012469A (enExample) |
| CN (1) | CN118076385A (enExample) |
| AU (1) | AU2022276189A1 (enExample) |
| BR (1) | BR112023024064A2 (enExample) |
| CA (1) | CA3220618A1 (enExample) |
| IL (1) | IL308607A (enExample) |
| MX (1) | MX2023013788A (enExample) |
| WO (1) | WO2022243937A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7805788B2 (ja) | 2019-05-23 | 2026-01-26 | ヤンセン バイオテツク，インコーポレーテツド | Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法 |
| IL298389A (en) | 2020-05-21 | 2023-01-01 | Janssen Biotech Inc | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
| MX2025013098A (es) * | 2023-05-03 | 2026-02-03 | Janssen Biotech Inc | Método para tratar la enfermedad de crohn con una combinación de anticuerpos contra il-23 y tnf alfa |
| KR20260007593A (ko) * | 2023-05-03 | 2026-01-14 | 얀센 바이오테크 인코포레이티드 | Il-23 및 tnf 알파에 대한 항체 조합에 의한 궤양성 대장염 치료 방법 |
| WO2025024723A1 (en) * | 2023-07-26 | 2025-01-30 | Sorriso Pharmaceuticals, Inc. | Il-23 and tnf-alpha induction treatment for autoimmune and inflammatory disorders |
| WO2025076251A1 (en) * | 2023-10-05 | 2025-04-10 | Sorriso Pharmaceuticals, Inc. | Dosages of il-23 and tnf-alpha inhibitors for use in autoimmune and inflammatory disorders |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DE229046T1 (de) | 1985-03-30 | 1987-12-17 | Marc Genf/Geneve Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| EP0832981A1 (en) | 1987-02-17 | 1998-04-01 | Pharming B.V. | DNA sequences to target proteins to the mammary gland for efficient secretion |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP0571613B1 (en) | 1991-12-13 | 2003-09-17 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| US6309663B1 (en) | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| SI2452694T1 (sl) | 2005-06-30 | 2019-05-31 | Janssen Biotech, Inc. | Protitelesa proti-IL-23, sestavki in postopki uporabe |
| MA46681A (fr) | 2016-01-28 | 2019-09-11 | Janssen Biotech Inc | Anticorps bispécifiques anti-tnf-alpha/il-17a antibodies et anticorps anti-tnf-alpha et leurs procédés d'utilisation |
| CA3037961A1 (en) | 2016-09-30 | 2018-04-05 | Janssen Biotech, Inc. | Safe and effective method of treating psoriasis with anti-il23 specific antibody |
| TWI744617B (zh) * | 2018-03-30 | 2021-11-01 | 美商美國禮來大藥廠 | 治療潰瘍性結腸炎之方法 |
| JP7805788B2 (ja) * | 2019-05-23 | 2026-01-26 | ヤンセン バイオテツク，インコーポレーテツド | Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法 |
| IL298389A (en) * | 2020-05-21 | 2023-01-01 | Janssen Biotech Inc | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
-
2022
- 2022-05-19 BR BR112023024064A patent/BR112023024064A2/pt unknown
- 2022-05-19 EP EP22727462.8A patent/EP4340875A1/en active Pending
- 2022-05-19 JP JP2023571449A patent/JP2024520202A/ja active Pending
- 2022-05-19 CA CA3220618A patent/CA3220618A1/en active Pending
- 2022-05-19 US US17/748,629 patent/US20220372129A1/en active Pending
- 2022-05-19 AU AU2022276189A patent/AU2022276189A1/en active Pending
- 2022-05-19 WO PCT/IB2022/054701 patent/WO2022243937A1/en not_active Ceased
- 2022-05-19 KR KR1020237043829A patent/KR20240012469A/ko active Pending
- 2022-05-19 MX MX2023013788A patent/MX2023013788A/es unknown
- 2022-05-19 IL IL308607A patent/IL308607A/en unknown
- 2022-05-19 CN CN202280050683.4A patent/CN118076385A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534020A5 (enExample) | ||
| JP2024520202A5 (enExample) | ||
| JP2023528265A5 (enExample) | ||
| Lin et al. | Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases | |
| JP7579227B2 (ja) | 瘻孔を伴うクローン病の治療用ベドリズマブ | |
| JP6955443B2 (ja) | 肺動脈性肺高血圧症の処置に関する方法および組成物 | |
| JP2021526534A5 (enExample) | ||
| JP2020500152A5 (enExample) | ||
| BR112021010789A2 (pt) | Anticorpos anti-il-36r para o tratamento de pustulose palmoplantar | |
| JP2021502349A5 (enExample) | ||
| JP2021515770A5 (enExample) | ||
| JP2020502261A5 (enExample) | ||
| CN106573056A (zh) | 用于诊断和治疗炎症性肠病的方法和组合物 | |
| JP2022547452A (ja) | Ａｃｔｒｉｉ受容体拮抗薬を含む肝疾患または肝臓障害の治療 | |
| CN118019550A (zh) | 预防、缓解或治疗黏膜黏连的药物及其应用 | |
| CN118647401A (zh) | 使用抗ige抗体治疗过敏反应 | |
| JP2022529929A5 (enExample) | ||
| JP2005505493A (ja) | 全身性エリテマトーデスの治療のための合成ヒトペプチド及びそれらを含む医薬組成物 | |
| Seni et al. | Advancements in ulcerative colitis management: a critical assessment of etrasimod therapy | |
| JP2023544620A5 (enExample) | ||
| JP2018535681A (ja) | Ｉｌ−３４アンチセンスオリゴヌクレオチドおよびその使用方法 | |
| JP2023524125A5 (enExample) | ||
| JP7297930B2 (ja) | クローン病を治療する方法に使用するためのミリキズマブ | |
| US20230049147A1 (en) | Anti-il-36r antibodies for the treatment of a fibrotic condition | |
| AU2003302368B2 (en) | Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |